国: オーストラリア
言語: 英語
ソース: Department of Health (Therapeutic Goods Administration)
Influenza virus haemagglutinin, Quantity: 30 microgram/mL
Seqirus Pty Ltd
Influenza virus haemagglutinin
Injection, suspension
Excipient Ingredients: monobasic potassium phosphate; thiomersal; calcium chloride dihydrate; dibasic sodium phosphate; sodium chloride; potassium chloride; monobasic sodium phosphate; water for injections
Subcutaneous, Intramuscular
Indicated for the prevention of influenza caused by influenza virus, types A and B.
Visual Identification: Clear to slightly opaque liquid containing some sediment which readily resuspends upon mixing; Container Type: Bulk Container; Container Life Time: 10 Weeks; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2004-08-06